Vijoice Tablet
Product Images NDC 0078-1021

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vijoice (NDC 0078-1021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alpelisib Structural Formula (Vijoice 01)

Chemical structure of alpelisib, the active ingredient in VIJOICE. The diagram shows the molecular framework including rings, functional groups, and substituents relevant to alpelisib.*

FDA Label Image

Principal Display Panel Vijoice™ (alpelisib) Tablets Ndc 0078-1021-84 50 mg Daily Dose Take One 50 mg Tablet Once Daily Rx Only Recommended Dosage: Take One 50 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information And Instruction For Patients Who Are Unable To Swallow Whole Tablets. 28-day Supply Contains: One Blister Pack Containing 28 Tablets Novartis (Vijoice 02)

Packaging label for VIJOICE 50 mg tablets containing alpelisib, an oral prescription drug by Novartis Pharmaceuticals Corporation. The box indicates a 28-day supply with one blister pack of 28 tablets. The label includes dosage instructions to take one 50 mg tablet once daily, storage conditions, and contact information for more details.*

FDA Label Image

Principal Display Panel Vijoice™ (alpelisib) Tablets Ndc 0078-1028-84 125 mg Daily Dose Take One 125 mg Tablet Once Daily Rx Only Recommended Dosage: Take One 125 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information And Instruction For Patients Who Are Unable To Swallow Whole Tablets. 28-day Supply Contains: One Blister Pack Containing 28 Tablets Novartis (Vijoice 03)

Vijoice 125 mg tablets carton packaging label for oral use. The label shows the proprietary name Vijoice with the generic name alpelisib, indicating a 125 mg daily dose. It includes usage instructions, storage information, and contains 28 tablets in a blister pack. Manufactured by Novartis Pharmaceuticals Corporation.*

FDA Label Image

Principal Display Panel Vijoice™ (alpelisib) Tablets Ndc 0078-1035-02 250 mg Daily Dose Take One 200 mg Tablet And One 50 mg Tablet Once Daily Rx Only Recommended Dosage: Take One 200 mg Tablet And One 50 mg Tablet Once Daily With Food. Swallow Tablets Whole. Do Not Chew, Crush, Or Split Tablets. See Prescribing Information For Complete Dosage Information And Instruction For Patients Who Are Unable To Swallow Whole Tablets. 28-day Supply (56 Tablets): Contains: Two 14-day Blister Packs Each Containing 28 Tablets: 200 mg 14 Tablets Per Pack 50 mg 14 Tablets Per Pack Novartis (Vijoice 04)

Packaging label for VIJOICE (alpelisib) tablets, showing a 250 mg daily dose consisting of one 200 mg tablet and one 50 mg tablet taken orally once daily. The label includes dosage instructions, storage guidelines, and package details for a 28-day supply containing 56 tablets in two 14-day blister packs. Manufactured by Novartis Pharma Stein AG and distributed by Novartis Pharmaceuticals Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.